PNC Financial Services Group’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,109
Closed -$281K 5202
2025
Q3
$281K Sell
19,109
-1,766
-8% -$18K ﹤0.01% 2066
2025
Q2
$205K Sell
20,875
-4,543
-18% -$37.6K ﹤0.01% 2186
2025
Q1
$185K Sell
25,418
-767
-3% -$6.71K ﹤0.01% 2227
2024
Q4
$205K Buy
26,185
+3,820
+17% +$31.5K ﹤0.01% 2197
2024
Q3
$166K Buy
22,365
+4,860
+28% +$40.9K ﹤0.01% 2335
2024
Q2
$140K Buy
17,505
+745
+4% +$6.65K ﹤0.01% 2391
2024
Q1
$195K Buy
16,760
+2,000
+14% +$22.1K ﹤0.01% 2191
2023
Q4
$165K Buy
14,760
+1,360
+10% +$12.5K ﹤0.01% 2288
2023
Q3
$207K Buy
13,400
+4,680
+54% +$78.6K ﹤0.01% 2096
2023
Q2
$165K Buy
8,720
+520
+6% +$9.13K ﹤0.01% 2339
2023
Q1
$125K Buy
+8,200
New +$107K ﹤0.01% 2429

Other funds holding ETNB

PNC Financial Services Group's ETNB Position: Q4 2025 in Review

PNC Financial Services Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 19,109 shares — an estimated $281K sold.

PNC Financial Services Group first reported a position in ETNB in Q1 2023 and held it in 11 quarters. The position peaked at $281K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • PNC Financial Services Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 19,109 89bio shares in Q4 2025, an estimated $281K.
  • PNC Financial Services Group first reported a position in 89bio in Q1 2023 and held it in 11 quarters.
  • PNC Financial Services Group's 89bio position peaked at $281K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.